SAMSUNG PHARM. Co., LTD. (001360.KS)
KSE · KRW · Healthcare · Drug Manufacturers - Specialty & Generic
₩1,254 (+0.00%) as of
Key statistics
- Market cap
- 118.03B
- Dividend yield
- 0.00%
- 52-week range
- 1,140.00 – 2,320.00
- Beta
- 0.73
- Revenue (TTM)
- 44.29B
- Profit margin
- 28.70%
- Volume
- 156.77k
About SAMSUNG PHARM. Co., LTD.
SAMSUNG PHARM. Co., LTD. manufactures and sells pharmaceutical products in South Korea. It offers prescription medicines, such as anticancer immunotherapy, antipyretic analgestic and antiinflammatory, antiobesity, hypotensive, antiarteriosclerotic, digestive organs, antophlegms, enzymes, ostepoposis, and transfusion agents, as well as skeletal muscle relaxants, anti-spastic, enzyme, mixed vitamins, antibiotics, and others. The company also provides medicines for the digestive system, medicines for liver disorders, medicines for the circulation system, cold medicines, nutritional supplements, health tonics, antophlegm agents, and others, as well as quasi-medicines, cold medicines, vitamins and energy drinks, and functional foods. The company was founded in 1929 and is headquartered in Hwaseong-si, South Korea.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Hwaseong-si, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.